Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images
2024-12-12 22:08
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW
2024-12-09 22:00
Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care
2024-12-05 22:07
Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
2024-12-02 22:00
Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging
2024-11-27 22:00
Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts
2024-11-25 22:00
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
2024-11-18 22:00
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network
2024-11-13 22:00
Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024
2024-11-08 22:00
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance
2024-10-23 21:00
Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024
2024-09-10 21:00
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing
2024-09-09 21:00
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR
2024-09-03 21:00
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study
2024-08-06 21:00
Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program
2024-07-22 21:00
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response
2024-05-24 22:07
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care
2024-05-22 21:00
Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite
2024-05-20 21:00
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals
2024-04-08 21:00
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification
2024-04-01 21:00
1
2
3
4
5